Aortic hemi-arch replacement for acute type A aortic dissection in an Abciximab-treated patient.
Tronc
F
F
Robin
J
J
Hanss
M
M
Ninet
J
J
D000077284:Abciximab; D000208:Acute Disease; D000784:Aortic Dissection / Q000097:blood / Q000601:surgery*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D001014:Aortic Aneurysm / Q000097:blood / Q000601:surgery*; D001777:Blood Coagulation / Q000187:drug effects; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D019917:Blood Vessel Prosthesis Implantation; D004334:Drug Administration Schedule; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D017713:Platelet Transfusion
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab